LSE - Delayed Quote GBp

Syncona Ord (SYNC.L)

96.90

-0.90

(-0.92%)

At close: 4:35:04 PM GMT

Syncona Ltd (LSE:SYNC) Half Year 2025 Earnings Call Highlights: Navigating Market Challenges ...

Despite a decline in NAV and portfolio value, Syncona Ltd (LSE:SYNC) remains optimistic with strategic investments and leadership enhancements.

GuruFocus.com 2 months ago

^YH103

AUTL
Purespring raises $105M to advance gene therapy for kidney disease

The Series B round will fund a Phase 1/2 trial of the company’s experimental treatment for IgA nephropathy.

BioPharma Dive 3 months ago

^YH103
Syncona melds two gene therapy biotechs for better shot at new nervous system treatments

The new company, Spur Therapeutics, is getting another $50 million from Syncona to support its broadened pipeline, which targets Parkinson’s disease as well as heart conditions.

BioPharma Dive 7 months ago

^YH103
Stocks to watch this week: Ashtead, Telecom Plus and DS Smith

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 7 months ago

DRI

SYNC.L
-0.92%
ACN

Performance Overview

Return	SYNC.L	FTSE 100
YTD	-6.10%	+6.48%
1-Year	-17.46%	+13.29%
3-Year	-46.23%	+15.82%